Viewing StudyNCT05245500

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 5:15 PM
Last Modification Date: 2024-10-26 @ 2:25 PM
Study NCT ID: NCT05245500
Status: RECRUITING
Last Update Posted: 2024-06-21
First Post: 2022-02-01
Brief Title: Phase 12 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Sponsor: Mirati Therapeutics Inc
Organization: Mirati Therapeutics Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Tumor
Mesothelioma
Non Small Cell Lung Cancer
Malignant Peripheral Nerve Sheath Tumors
Solid Tumor
Pancreatic Adenocarcinoma
Keywords:
Name View
NSCLC View
MTAP Deletion View
Mesothelioma View
Non Small Cell Lung Cancer View
Malignant Peripheral Nerve Sheath Tumors View
Solid Tumor View
MTAP View
Malignant View
Pancreatic adenocarcinoma View
Pancreas Cancer View
PRMT5 View
Synthetic Lethality View
Advanced Solid Tumor View